• 1456 Citations
  • 19 h-Index
19962020
If you made any changes in Pure these will be visible here soon.

Personal profile

Education

  • 私立台北醫學院醫學系學士

Research Interests

  • 心臟血管急重症學
  • 超音波心圖學
  • 診斷治療性心導管術

Fingerprint Dive into the research topics where Ting-Hsing Chao is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 35 Similar Profiles
Taiwan Medicine & Life Sciences
Thrombomodulin Medicine & Life Sciences
Myocardial Infarction Medicine & Life Sciences
Coronary Artery Disease Medicine & Life Sciences
Hydroxymethylglutaryl-CoA Reductase Inhibitors Medicine & Life Sciences
Blood Vessels Medicine & Life Sciences
Guidelines Medicine & Life Sciences
Endothelial Cells Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2003 2020

Research Output 1996 2019

  • 1456 Citations
  • 19 h-Index
  • 96 Article
  • 5 Review article
  • 2 Letter
  • 1 Comment/debate
1 Citation (Scopus)

A subanalysis of Taiwanese patients from ODYSSEY South Korea and Taiwan study evaluating the efficacy and safety of alirocumab

Chao, T. H., Hsiao, P. J., Liu, M. E., Wu, C. J., Chiang, F. T., Chen, Z. C., Chen, C. P., Yeh, H. I., Lee, T. H. & Chiang, C. E., 2019 Jan 1, In : Journal of the Chinese Medical Association. 82, 4, p. 265-271 7 p.

Research output: Contribution to journalArticle

Republic of Korea
Taiwan
LDL Cholesterol
Safety
Placebos

The role of vascular smooth muscle cell membrane-bound thrombomodulin in neointima formation

Wang, K. C., Chen, P. S., Chao, T. H., Luo, C. Y., Chung, H. C., Tseng, S. Y., Huang, T. Y., Lin, Y. L., Shi, G. Y., Wu, H. L. & Li, Y. H., 2019 Aug, In : Atherosclerosis. 287, p. 54-63 10 p.

Research output: Contribution to journalArticle

Thrombomodulin
Neointima
Vascular Smooth Muscle
Smooth Muscle Myocytes
Cell Membrane
5 Citations (Scopus)

2018 consensus of the Taiwan Society of Cardiology and the Diabetes Association of Republic of China (Taiwan) on the pharmacological management of patients with type 2 diabetes and cardiovascular diseases

Chiang, C. E., Lin, S. Y., Lin, T. H., Wang, T. D., Yeh, H. I., Chen, J. F., Tsai, C. T., Hung, Y. J., Li, Y-H., Liu, P-Y., Chang, K. C., Wang, K. L., Chao, T-H., Shyu, K. G., Yang, W. S., Ueng, K. C., Chu, P. H., Yin, W. H., Wu, Y. W., Cheng, H. M. & 7 others, Shin, S. J., Huang, C. N., Chuang, L. M., Lin, S. J., Yeh, S. J., Sheu, W. H. H. & Lin, J. L., 2018 Mar 1, In : Journal of the Chinese Medical Association. 81, 3, p. 189-222 34 p.

Research output: Contribution to journalArticle

Cardiology
Taiwan
Type 2 Diabetes Mellitus
Cardiovascular Diseases
Pharmacology
13 Citations (Scopus)

A randomized trial evaluating the efficacy and safety of alirocumab in South Korea and Taiwan (ODYSSEY KT)

Koh, K. K., Nam, C. W., Chao, T. H., Liu, M. E., Wu, C. J., Kim, D. S., Kim, C. J., Li, I., Li, J., Baccara-Dinet, M. T., Hsiao, P. J. & Chiang, C. E., 2018 Jan, In : Journal of Clinical Lipidology. 12, 1, p. 162-172.e6

Research output: Contribution to journalArticle

Republic of Korea
Taiwan
Safety
LDL Cholesterol
Placebos
14 Citations (Scopus)
clopidogrel
Taiwan
Myocardial Infarction
Hemorrhage
Safety